Skip to content

I just returned from a Labor Day holiday trip to Chicago for a cousin's wedding. It was a wonderful weekend with extended family sprinkled in …

Published on

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.

Stanford researchers just announced that by using a new antibody against a cell protein called CD47, along with an existing anti-cancer antibody, they were able to cure well over half of the mice that had been given a human leukemia called non-Hodgkins lymphoma.